/OKYO.L
OKYO.L Stock - OKYO Pharma Limited
Healthcare|BiotechnologyLSE
$1.40-24.32%
$0.45 (-24.32%) • May 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.54
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OKYO.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.39 – $1.41
TARGET (TP)$1.61
STOP LOSS$1.29
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.06
52W High$8.50
52W Low$1.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-2,563 | $-7,506 | $-3,797 | $-2,423 | $-13,086 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-7,188,875 | $-15,694,549 | $-13,187,000 | $-6,231,000 | $-4,133,349 |
| Net Income | $-4,706,292 | $-16,825 | $-13,272,000 | $-5,431,000 | $-3,354,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.12 | $-0.00 | $-0.60 | $-0.36 | $-0.32 |
Company Overview
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
OKYO.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.09
Q1 2025
EPS Surprise History
Q1 21
No data
Q3 21
No data
Q1 22
No data
Q4 22
No data
Q1 23
No data
Q4 23
No data
Q1 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Mar 31, 2025 | — | $-0.09 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-0.00 | — | — |
Q4 2023 | Dec 28, 2023 | — | — | — | — |
Q4 2023 | Oct 1, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 14, 2023 | — | — | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 30, 2022 | — | — | — | — |
Q4 2022 | Oct 1, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.27 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.19 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.09 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.04 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.10 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.00 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.00 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.00 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.00 | — | — |
Q1 2017 | Mar 31, 2017 | — | $-0.00 | — | — |
Q3 2016 | Sep 30, 2016 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about OKYO.L
What is OKYO.L's current stock price?
OKYO Pharma Limited (OKYO.L) is currently trading at $1.40 per share. The stock has moved -24.32% today.
What is the analyst price target for OKYO.L?
No analyst price targets are currently available for this stock.
What sector is OKYO Pharma Limited in?
OKYO Pharma Limited operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the LSE exchange.
What is OKYO.L's market cap?
OKYO Pharma Limited has a market capitalization of $0.02 billion, making it a small-cap company.
Does OKYO.L pay dividends?
No, OKYO Pharma Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBVX.L
BiVictriX Therapeutics Plc
$10.00
Mkt Cap: $0.8B
C4XD.L
C4X Discovery Holdings plc
$12.00
Mkt Cap: $3.0B
DEST.L
Destiny Pharma plc
$3.00
Mkt Cap: $0.3B
MTPH.L
Midatech Pharma plc
$18.00
Mkt Cap: $3.1B
NSCI.L
NetScientific plc
$53.12
Mkt Cap: $1.3B
OCTP.L
Oxford Cannabinoid Technologies Holdings Plc
$0.12
Mkt Cap: $0.1B
RENE.L
ReNeuron Group plc
$3.38
Mkt Cap: $0.2B
SNG.L
Synairgen plc
$0.95
Mkt Cap: $1.2B
TCF.L
Theracryf Plc
$0.20
Mkt Cap: $0.4B
YGEN.L
Yourgene Health Plc
$0.51
Mkt Cap: $1.6B
Explore stocks similar to OKYO.L for comparison